Countdown to Clorox (CLX) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Core Insights - Clorox (CLX) is expected to report quarterly earnings of $2.24 per share, a 23.1% increase year-over-year, with revenues projected at $1.93 billion, reflecting a 1.5% increase compared to the same period last year [1] Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been revised downward by 3.2%, indicating a reassessment by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts predict 'Net Revenue- Health and Wellness' at $692.86 million, a 6.3% increase year-over-year [5] - 'Net Revenue- International' is estimated to be $249.98 million, showing a decline of 7.8% year-over-year [5] - The consensus for 'Net Revenue- Lifestyle' stands at $349.59 million, indicating a 6.6% increase from the previous year [5] - 'Net Revenue- Household' is estimated at $626.55 million, reflecting a 5% increase year-over-year [6] Income Estimates - 'Income before income taxes- Health and Wellness' is expected to reach $219.10 million, up from $202.00 million year-over-year [7] - 'Income before income taxes- International' is projected at $21.21 million, compared to $18.00 million last year [7] - 'Income before income taxes- Lifestyle' is likely to be $71.73 million, an increase from $61.00 million in the same quarter last year [8] - 'Income before income taxes- Household' is estimated at $102.89 million, compared to $98.00 million year-over-year [8] Stock Performance - Clorox shares have increased by 2.8% over the past month, while the Zacks S&P 500 composite has risen by 3.4% [8] - Clorox holds a Zacks Rank 5 (Strong Sell), indicating expected underperformance relative to the overall market in the near term [8]